| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcopenia | 13 | 2022 | 66 | 6.000 |
Why?
|
| Tomography, X-Ray Computed | 34 | 2022 | 949 | 4.520 |
Why?
|
| Bone Density | 31 | 2021 | 203 | 4.460 |
Why?
|
| Osteoporosis | 19 | 2021 | 71 | 4.000 |
Why?
|
| Absorptiometry, Photon | 24 | 2019 | 136 | 2.280 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2022 | 1307 | 2.080 |
Why?
|
| Radiology | 10 | 2019 | 45 | 1.930 |
Why?
|
| Diabetes Mellitus, Type 2 | 15 | 2019 | 1462 | 1.500 |
Why?
|
| Psoas Muscles | 4 | 2019 | 19 | 1.430 |
Why?
|
| Humans | 133 | 2022 | 32814 | 1.260 |
Why?
|
| Algorithms | 5 | 2019 | 511 | 1.140 |
Why?
|
| Tendons | 11 | 2019 | 59 | 1.010 |
Why?
|
| Spinal Fractures | 4 | 2018 | 43 | 0.930 |
Why?
|
| Fractures, Bone | 4 | 2020 | 162 | 0.890 |
Why?
|
| Body Composition | 14 | 2021 | 388 | 0.820 |
Why?
|
| Muscle, Skeletal | 8 | 2021 | 524 | 0.780 |
Why?
|
| Aged | 41 | 2022 | 10544 | 0.780 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2019 | 23 | 0.760 |
Why?
|
| Female | 68 | 2020 | 20271 | 0.750 |
Why?
|
| Male | 63 | 2020 | 19650 | 0.730 |
Why?
|
| Ankle Joint | 5 | 2019 | 52 | 0.720 |
Why?
|
| Middle Aged | 52 | 2020 | 12133 | 0.710 |
Why?
|
| Weight Loss | 10 | 2019 | 457 | 0.670 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 197 | 0.660 |
Why?
|
| Research | 3 | 2017 | 76 | 0.640 |
Why?
|
| Spine | 8 | 2021 | 44 | 0.640 |
Why?
|
| Diagnostic Imaging | 7 | 2019 | 97 | 0.640 |
Why?
|
| Adipose Tissue | 7 | 2019 | 349 | 0.630 |
Why?
|
| Bone and Bones | 6 | 2018 | 94 | 0.630 |
Why?
|
| African Americans | 7 | 2018 | 1424 | 0.630 |
Why?
|
| Obesity | 13 | 2019 | 1152 | 0.610 |
Why?
|
| Injury Severity Score | 1 | 2019 | 111 | 0.610 |
Why?
|
| Molecular Probe Techniques | 2 | 2015 | 4 | 0.560 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2015 | 11 | 0.550 |
Why?
|
| Molecular Probes | 2 | 2015 | 16 | 0.550 |
Why?
|
| Knee Joint | 10 | 2017 | 143 | 0.550 |
Why?
|
| Radius | 1 | 2017 | 26 | 0.540 |
Why?
|
| Molecular Imaging | 2 | 2015 | 20 | 0.540 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2004 | 12 | 0.520 |
Why?
|
| Hip Fractures | 1 | 2017 | 30 | 0.520 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 112 | 0.510 |
Why?
|
| Mortality | 1 | 2017 | 124 | 0.510 |
Why?
|
| Survival Analysis | 2 | 2018 | 486 | 0.510 |
Why?
|
| Lumbar Vertebrae | 7 | 2022 | 110 | 0.490 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 1163 | 0.480 |
Why?
|
| Thoracic Vertebrae | 3 | 2018 | 44 | 0.480 |
Why?
|
| Societies, Medical | 8 | 2021 | 163 | 0.430 |
Why?
|
| Aged, 80 and over | 20 | 2019 | 4034 | 0.420 |
Why?
|
| Exercise | 8 | 2018 | 679 | 0.420 |
Why?
|
| Mass Screening | 3 | 2020 | 268 | 0.380 |
Why?
|
| Reproducibility of Results | 9 | 2021 | 767 | 0.360 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2018 | 40 | 0.350 |
Why?
|
| United States | 11 | 2021 | 4109 | 0.350 |
Why?
|
| Sensitivity and Specificity | 11 | 2019 | 576 | 0.340 |
Why?
|
| Ultrasonography | 9 | 2018 | 381 | 0.330 |
Why?
|
| Evidence-Based Medicine | 6 | 2021 | 215 | 0.320 |
Why?
|
| Prevalence | 5 | 2020 | 1002 | 0.320 |
Why?
|
| Adult | 31 | 2019 | 9569 | 0.320 |
Why?
|
| Pelvic Bones | 4 | 2016 | 34 | 0.310 |
Why?
|
| Tibia | 3 | 2014 | 60 | 0.300 |
Why?
|
| Organ Size | 3 | 2019 | 219 | 0.300 |
Why?
|
| Diet, Reducing | 5 | 2009 | 100 | 0.290 |
Why?
|
| Synovial Fluid | 2 | 2019 | 8 | 0.290 |
Why?
|
| Wrist Injuries | 2 | 2019 | 47 | 0.290 |
Why?
|
| Osteomyelitis | 2 | 2019 | 29 | 0.280 |
Why?
|
| Sex Factors | 4 | 2019 | 676 | 0.280 |
Why?
|
| Retrospective Studies | 13 | 2020 | 3705 | 0.260 |
Why?
|
| Densitometry | 3 | 2002 | 8 | 0.260 |
Why?
|
| Joint Diseases | 5 | 2017 | 36 | 0.260 |
Why?
|
| Foot | 2 | 2018 | 41 | 0.260 |
Why?
|
| Wrist | 3 | 2020 | 48 | 0.250 |
Why?
|
| Heart | 5 | 2009 | 185 | 0.250 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 764 | 0.240 |
Why?
|
| Ligaments, Articular | 5 | 2019 | 50 | 0.240 |
Why?
|
| Contrast Media | 5 | 2019 | 139 | 0.230 |
Why?
|
| Trauma Severity Indices | 2 | 2015 | 49 | 0.230 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 43 | 0.230 |
Why?
|
| Tendon Injuries | 3 | 2015 | 40 | 0.230 |
Why?
|
| Osteoarthritis, Knee | 2 | 2021 | 81 | 0.230 |
Why?
|
| Collateral Ligaments | 2 | 2014 | 9 | 0.220 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 11 | 0.220 |
Why?
|
| Cartilage, Articular | 3 | 2021 | 75 | 0.220 |
Why?
|
| Age Factors | 2 | 2019 | 1197 | 0.210 |
Why?
|
| Bone Diseases | 3 | 2019 | 19 | 0.210 |
Why?
|
| Risk Factors | 5 | 2019 | 3976 | 0.210 |
Why?
|
| Registries | 2 | 2015 | 315 | 0.210 |
Why?
|
| Knee | 2 | 2021 | 31 | 0.210 |
Why?
|
| Osteochondritis Dissecans | 2 | 2000 | 16 | 0.210 |
Why?
|
| Aging | 4 | 2019 | 938 | 0.210 |
Why?
|
| Radiography, Abdominal | 2 | 2019 | 16 | 0.210 |
Why?
|
| Menisci, Tibial | 4 | 2000 | 23 | 0.200 |
Why?
|
| Radiography | 5 | 2016 | 386 | 0.200 |
Why?
|
| Chondrocalcinosis | 2 | 2020 | 2 | 0.200 |
Why?
|
| Diagnosis, Differential | 10 | 2018 | 526 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 98 | 0.190 |
Why?
|
| Motor Vehicles | 2 | 2020 | 25 | 0.190 |
Why?
|
| Proteins | 1 | 2003 | 142 | 0.190 |
Why?
|
| Lumbosacral Region | 1 | 2022 | 11 | 0.190 |
Why?
|
| Body Mass Index | 8 | 2015 | 908 | 0.180 |
Why?
|
| Space Flight | 1 | 2022 | 23 | 0.180 |
Why?
|
| Cadaver | 9 | 2019 | 165 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 412 | 0.180 |
Why?
|
| Fingers | 2 | 2015 | 69 | 0.180 |
Why?
|
| Femur Neck | 2 | 2017 | 21 | 0.170 |
Why?
|
| Medical Records | 2 | 2017 | 77 | 0.170 |
Why?
|
| Ribs | 2 | 2016 | 47 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2019 | 369 | 0.170 |
Why?
|
| Prognosis | 3 | 2019 | 1545 | 0.160 |
Why?
|
| Phantoms, Imaging | 1 | 2020 | 59 | 0.160 |
Why?
|
| Cartilage Diseases | 2 | 2019 | 21 | 0.160 |
Why?
|
| Metatarsalgia | 1 | 2019 | 1 | 0.160 |
Why?
|
| Toes | 1 | 2019 | 16 | 0.160 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 9 | 0.160 |
Why?
|
| Sarcoma | 1 | 2020 | 71 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2019 | 51 | 0.150 |
Why?
|
| Abdominal Muscles | 1 | 2019 | 6 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 39 | 0.150 |
Why?
|
| Pubic Symphysis | 1 | 2019 | 4 | 0.150 |
Why?
|
| Automation | 1 | 2019 | 30 | 0.150 |
Why?
|
| Radiology Information Systems | 2 | 2017 | 13 | 0.150 |
Why?
|
| Diabetic Foot | 1 | 2019 | 26 | 0.150 |
Why?
|
| Ankle | 2 | 2018 | 31 | 0.150 |
Why?
|
| Forensic Medicine | 1 | 2019 | 14 | 0.150 |
Why?
|
| Knee Injuries | 3 | 2017 | 40 | 0.150 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 92 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2019 | 64 | 0.150 |
Why?
|
| Autopsy | 1 | 2019 | 33 | 0.150 |
Why?
|
| Radiation Dosage | 1 | 2019 | 84 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 72 | 0.150 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 1140 | 0.150 |
Why?
|
| Hand Injuries | 1 | 2019 | 24 | 0.150 |
Why?
|
| Burnout, Professional | 1 | 2020 | 53 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2285 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 779 | 0.150 |
Why?
|
| Wrist Joint | 1 | 2019 | 60 | 0.150 |
Why?
|
| Adiponectin | 2 | 2013 | 103 | 0.140 |
Why?
|
| Compressive Strength | 1 | 2018 | 22 | 0.140 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2018 | 9 | 0.140 |
Why?
|
| Hallux | 1 | 2018 | 10 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 573 | 0.140 |
Why?
|
| Shoulder Pain | 1 | 2018 | 10 | 0.140 |
Why?
|
| Foot Joints | 1 | 2017 | 2 | 0.140 |
Why?
|
| Lower Extremity | 2 | 2018 | 107 | 0.140 |
Why?
|
| Medicare | 1 | 2019 | 213 | 0.140 |
Why?
|
| Elbow Joint | 2 | 2014 | 66 | 0.140 |
Why?
|
| Calcinosis | 3 | 2016 | 146 | 0.130 |
Why?
|
| Causality | 1 | 2017 | 39 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 300 | 0.130 |
Why?
|
| California | 1 | 2017 | 66 | 0.130 |
Why?
|
| Patellofemoral Joint | 1 | 2017 | 14 | 0.130 |
Why?
|
| Education, Medical | 1 | 2017 | 70 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2017 | 58 | 0.130 |
Why?
|
| Resistance Training | 1 | 2017 | 77 | 0.130 |
Why?
|
| Nerve Compression Syndromes | 2 | 2015 | 9 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 888 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 295 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2016 | 788 | 0.120 |
Why?
|
| Sternoclavicular Joint | 1 | 2016 | 4 | 0.120 |
Why?
|
| Popliteal Cyst | 1 | 1996 | 1 | 0.120 |
Why?
|
| Sternum | 1 | 2016 | 14 | 0.120 |
Why?
|
| Clavicle | 1 | 2016 | 15 | 0.120 |
Why?
|
| Lipoma | 1 | 2016 | 7 | 0.120 |
Why?
|
| Osteosclerosis | 1 | 2016 | 1 | 0.120 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 3 | 0.120 |
Why?
|
| North Carolina | 2 | 2018 | 1546 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2017 | 92 | 0.120 |
Why?
|
| Aortic Diseases | 1 | 2016 | 62 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2016 | 116 | 0.120 |
Why?
|
| Tomography, Spiral Computed | 2 | 2006 | 19 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2016 | 164 | 0.110 |
Why?
|
| Ligaments | 1 | 2015 | 14 | 0.110 |
Why?
|
| Finger Injuries | 1 | 2015 | 9 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 332 | 0.110 |
Why?
|
| Fractures, Stress | 1 | 2015 | 12 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 2014 | 20 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 72 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2015 | 45 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2014 | 56 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 1 | 2014 | 43 | 0.110 |
Why?
|
| Hip | 3 | 2003 | 15 | 0.110 |
Why?
|
| Disease Progression | 1 | 2016 | 594 | 0.110 |
Why?
|
| Psoas Abscess | 1 | 1994 | 1 | 0.110 |
Why?
|
| Fibroma | 1 | 2013 | 10 | 0.100 |
Why?
|
| Hematoma | 1 | 1994 | 27 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2014 | 39 | 0.100 |
Why?
|
| Life Style | 2 | 2014 | 407 | 0.100 |
Why?
|
| Physical Fitness | 1 | 2014 | 133 | 0.100 |
Why?
|
| Adolescent | 7 | 2016 | 3640 | 0.100 |
Why?
|
| Gait | 1 | 2014 | 140 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 225 | 0.090 |
Why?
|
| Young Adult | 5 | 2019 | 2734 | 0.090 |
Why?
|
| C-Reactive Protein | 3 | 2013 | 237 | 0.090 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 145 | 0.090 |
Why?
|
| Mobility Limitation | 1 | 2014 | 220 | 0.090 |
Why?
|
| Adiposity | 1 | 2013 | 198 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2017 | 1461 | 0.090 |
Why?
|
| Energy Intake | 2 | 2009 | 128 | 0.090 |
Why?
|
| Sarcoma, Synovial | 1 | 1991 | 6 | 0.090 |
Why?
|
| Hemangioma | 1 | 1991 | 22 | 0.080 |
Why?
|
| Exercise Therapy | 2 | 2019 | 271 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 835 | 0.080 |
Why?
|
| Joint Capsule | 2 | 2000 | 8 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Forearm | 2 | 2014 | 46 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 22 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2009 | 51 | 0.080 |
Why?
|
| Postmenopause | 5 | 2009 | 427 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 881 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2009 | 47 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 134 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2009 | 155 | 0.070 |
Why?
|
| Neoplasms | 2 | 1997 | 762 | 0.070 |
Why?
|
| Sex Characteristics | 4 | 2013 | 172 | 0.070 |
Why?
|
| Archaeology | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cooking and Eating Utensils | 1 | 2006 | 1 | 0.060 |
Why?
|
| Soil | 1 | 2006 | 1 | 0.060 |
Why?
|
| Alloys | 1 | 2006 | 2 | 0.060 |
Why?
|
| Copper | 1 | 2006 | 11 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 27 | 0.060 |
Why?
|
| Animals | 2 | 2015 | 7570 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 1066 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 84 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 195 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 43 | 0.060 |
Why?
|
| Fractures, Spontaneous | 2 | 2002 | 15 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 136 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1572 | 0.050 |
Why?
|
| Nuclear Family | 1 | 2004 | 15 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 44 | 0.050 |
Why?
|
| Patella | 3 | 2000 | 20 | 0.050 |
Why?
|
| Rib Fractures | 1 | 2004 | 21 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2003 | 6 | 0.050 |
Why?
|
| Leptin | 1 | 2003 | 73 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 69 | 0.050 |
Why?
|
| Bone Neoplasms | 2 | 2002 | 117 | 0.050 |
Why?
|
| Arthroscopy | 2 | 2007 | 249 | 0.050 |
Why?
|
| Inflammation | 1 | 2005 | 536 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2002 | 148 | 0.040 |
Why?
|
| Back Pain | 1 | 2021 | 29 | 0.040 |
Why?
|
| Patellar Ligament | 2 | 2000 | 6 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 77 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 563 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2002 | 72 | 0.040 |
Why?
|
| Alendronate | 1 | 2001 | 11 | 0.040 |
Why?
|
| Joint Loose Bodies | 1 | 2000 | 7 | 0.040 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2001 | 35 | 0.040 |
Why?
|
| Tarsal Bones | 1 | 2000 | 5 | 0.040 |
Why?
|
| Temporomandibular Joint | 1 | 2020 | 3 | 0.040 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2000 | 18 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2001 | 114 | 0.040 |
Why?
|
| Extremities | 1 | 2020 | 54 | 0.040 |
Why?
|
| Faculty | 1 | 2020 | 15 | 0.040 |
Why?
|
| Rotator Cuff | 1 | 2000 | 74 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 24 | 0.040 |
Why?
|
| Calibration | 1 | 2019 | 28 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 326 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 44 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2020 | 119 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2020 | 41 | 0.040 |
Why?
|
| Pubic Bone | 1 | 2019 | 1 | 0.040 |
Why?
|
| Femur | 2 | 2015 | 79 | 0.040 |
Why?
|
| Thigh | 1 | 2019 | 40 | 0.040 |
Why?
|
| Range of Motion, Articular | 2 | 2017 | 195 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 1999 | 23 | 0.040 |
Why?
|
| Reference Values | 2 | 2014 | 238 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2000 | 2329 | 0.040 |
Why?
|
| Peroneal Nerve | 2 | 2015 | 15 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 179 | 0.040 |
Why?
|
| Low Back Pain | 1 | 1999 | 47 | 0.040 |
Why?
|
| Tibial Nerve | 2 | 2015 | 21 | 0.040 |
Why?
|
| Osteitis Deformans | 1 | 1998 | 2 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 471 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 112 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2018 | 25 | 0.040 |
Why?
|
| Granuloma Annulare | 1 | 1998 | 2 | 0.040 |
Why?
|
| Shoulder Joint | 1 | 2000 | 137 | 0.040 |
Why?
|
| Cysts | 1 | 1998 | 17 | 0.040 |
Why?
|
| Body Fluids | 1 | 1998 | 8 | 0.030 |
Why?
|
| Edema | 1 | 1998 | 27 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 894 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2018 | 83 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2018 | 39 | 0.030 |
Why?
|
| Body Weight | 1 | 2019 | 301 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2018 | 74 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 783 | 0.030 |
Why?
|
| Myositis Ossificans | 1 | 1997 | 3 | 0.030 |
Why?
|
| Foot Diseases | 1 | 1997 | 12 | 0.030 |
Why?
|
| Physical Examination | 1 | 2017 | 89 | 0.030 |
Why?
|
| Hamartoma | 1 | 1997 | 10 | 0.030 |
Why?
|
| Software | 1 | 2017 | 124 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 150 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 51 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Geriatric Assessment | 2 | 2014 | 388 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 422 | 0.030 |
Why?
|
| Health Education | 1 | 1997 | 162 | 0.030 |
Why?
|
| Radiology Department, Hospital | 1 | 2015 | 4 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Workflow | 1 | 2015 | 20 | 0.030 |
Why?
|
| Professional Practice | 1 | 2015 | 24 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 29 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2015 | 34 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2016 | 86 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 102 | 0.030 |
Why?
|
| Artifacts | 1 | 2015 | 42 | 0.030 |
Why?
|
| Sural Nerve | 1 | 2015 | 27 | 0.030 |
Why?
|
| Glioma, Subependymal | 1 | 1995 | 2 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1995 | 5 | 0.030 |
Why?
|
| Clinical Medicine | 1 | 2015 | 13 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 143 | 0.030 |
Why?
|
| Respiration | 1 | 1994 | 28 | 0.030 |
Why?
|
| Diaphragm | 1 | 1994 | 38 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1994 | 23 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2013 | 13 | 0.020 |
Why?
|
| Independent Living | 1 | 2014 | 105 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 63 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 2183 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1998 | 1282 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 565 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Medial Collateral Ligament, Knee | 2 | 2000 | 6 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 68 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2009 | 15 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 110 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 185 | 0.020 |
Why?
|
| Gadolinium | 2 | 2000 | 20 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 92 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 125 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 288 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 459 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2009 | 101 | 0.020 |
Why?
|
| Europe | 1 | 2007 | 83 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 74 | 0.020 |
Why?
|
| Overweight | 1 | 2009 | 263 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 89 | 0.020 |
Why?
|
| Belgium | 1 | 2006 | 1 | 0.020 |
Why?
|
| Rome | 1 | 2006 | 2 | 0.020 |
Why?
|
| History, Ancient | 1 | 2006 | 5 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 622 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 494 | 0.020 |
Why?
|
| Estrogens | 1 | 2007 | 169 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2006 | 22 | 0.020 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2006 | 14 | 0.020 |
Why?
|
| Cell Size | 1 | 2006 | 36 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 532 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 171 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 98 | 0.010 |
Why?
|
| Walking | 1 | 2006 | 210 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 877 | 0.010 |
Why?
|
| Viscera | 1 | 2005 | 17 | 0.010 |
Why?
|
| Waist-Hip Ratio | 1 | 2005 | 35 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 258 | 0.010 |
Why?
|
| Serum | 1 | 2004 | 16 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 38 | 0.010 |
Why?
|
| Pericardium | 1 | 2005 | 55 | 0.010 |
Why?
|
| Osteolysis | 1 | 2004 | 7 | 0.010 |
Why?
|
| Bone Cysts | 1 | 2004 | 5 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 135 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 240 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 152 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 525 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 208 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 183 | 0.010 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 38 | 0.010 |
Why?
|
| African Continental Ancestry Group | 1 | 2004 | 363 | 0.010 |
Why?
|
| Diet | 1 | 2005 | 390 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 531 | 0.010 |
Why?
|
| Fascia | 1 | 2000 | 10 | 0.010 |
Why?
|
| Arthrography | 1 | 2000 | 10 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2000 | 20 | 0.010 |
Why?
|
| Rupture | 1 | 2000 | 34 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2000 | 70 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 636 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3441 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1998 | 4 | 0.010 |
Why?
|
| Buttocks | 1 | 1998 | 6 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1998 | 79 | 0.010 |
Why?
|
| Median Nerve | 1 | 1997 | 49 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 214 | 0.010 |
Why?
|
| Hypertension | 1 | 2000 | 976 | 0.010 |
Why?
|